2 - Step 3 treatment plan Flashcards
What is step 1 of the periodontal treatment plan?
- education and explanation
- OHI
- risk factor control
- PMPR
- arrange review
How should you approach PMPR?
- if you can see it, remove it
- aids patient to keep mouth clean
What OHI should you give to patients?
- small head, medium textured bristles
- oscillating and rotating
- interdental cleaning brushes should fit snuggly without wire touching teeth
- use floss if the papilla is intact
How often should you review periodontal patients?
- flexible, 6-8 weeks
- review OH after 3 weeks
- response is quick but the healing is slow
What is the difference between marginal bleeding and BPE?
- marginal bleeding indicates how well the patient brushes
- BPE indicates inflammation at the base of the pocket (active disease)
What do you evaluate at the step 1 review?
- good OHI? (relative improvement, ideally plaque <20%)
- no BOP (<10%)
- no pockets > 4mm
- no increasing tooth mobility
- functional and comfortable dentition
What is step 2 of the periodontal treatment plan?
- step 1, in addition:
- instrumentation of pockets > 4mm
What are the steps you can take if you have a non-engaging patient?
- find out why and support if possible
- repeat cause-related therapy
- place on palliative care (supportive plan) if uninterested or unable
What do you evaluate at the step 2 review?
Good OH and inflammation resolved = supportive care
Good OH and persistent disease = repeat RSD or consider surgical access
What are the different types of periodontal surgery?
- access flap
- resective
- regenerative
What are the guidelines for considering periodontal surgery?
PPD 4-5mm = repeated RSD
PPD >6 mm = surgical
What decisions influence the decision for surgery?
- smoking
- compliance
- OH (lower threshold for plaque)
- systemic disease
- site and prognosis
What is the ideal endpoint of periodontal treatment?
- no pockets > 4mm
- no BOP on pockets of 4mm
- BOP <10%
- functional and comfortable dentition
- plaque scores < 20%
What is supportive periodontal therapy?
- risk adapted intervals 3-12 months
- continuous monitoring
- PMPR